Follow-The-Filings

Security · featured owners

APYX Apyx Med Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $3M
  • 1 reduce

APYX (Apyx Med Corp.) is held in 1 featured 13F book as of 2026 Q2. Murray Stahl - Horizon Kinetics Asset Management is the largest tracked holder by portfolio weight (0.03%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (Murray Stahl - Horizon Kinetics Asset Management) · not free-float ownership

  1. Murray Stahl Reduce 0.03%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.03% Reduce −4.9% 585,000 $3M History

1 current · options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 11, 2026 · 8 forms Filing Doc
4 Period Mar 15, 2026 Filing Doc
4 Period Jan 27, 2026 Filing Doc
4 Period May 15, 2025 · 5 forms Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $52.35M $48.1M $52.84M
Gross profit $33.76M $29.36M $33.04M
Gross margin * 64.5% 61.0% 62.5%
Net income -$18.71M -$23.46M -$11.21M
Net margin * -35.7% -48.8% -21.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $70.36M $56.44M $58.47M
Total non-current assets * $8.88M $8.4M $8.37M
Total assets $79.24M $64.84M $66.84M
Total current liabilities $12.74M $10.72M $11.7M
Total non-current liabilities * $39.58M $39.79M $40.31M
Total equity $26.7M $14.21M $14.54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$5.25M -$18.05M -$8M
Cash from investing $6.73M -$0.722M -$1.11M
Cash from financing $32.17M $6.74M $9.58M
Net change in cash $33.46M -$11.91M -$0.001M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders